Table 5.

Correlation of postvaccination percentage increase in serum MCP-1 levels with known clinical prognostic variables in MCP-low breast cancer patients

Response-low (<50%, ↑ MCP-1), n = 15Response-high (>50%, ↑ MCP-1), n = 7P
Age (average)54.452.40.58
Race (% not Caucasian)20140.79
Grade (% poorly differentiated)33860.03
% Stage 2 or higher40860.04
% T2 or larger7710.01
% Node-positive40570.77
Average nodes positive1.12.40.33
% Estrogen/progesterone receptor negative29430.87
% HER-2/neu+31430.79
% Received chemotherapy641000.20
Average MCP-1 response27%90%0.003